Robert F. Kennedy Jr., now serving as secretary of the Department of Health and Human Services, is pursuing an expedited appeal after a federal judge blocked his efforts to restart a government vaccine advisory panel. The judge froze the panel's operations and barred it from convening, halting Kennedy's push to reshape federal vaccine policy.
Kennedy sought to revive the Advisory Commission on Childhood Vaccines, which had been largely inactive. The panel advises the government on vaccine safety and injury compensation claims. A federal judge intervened, blocking the commission from meeting and preventing it from issuing new decisions that could alter existing vaccine recommendations.
The legal dispute centers on Kennedy's authority to restructure how the government approaches vaccine policy. Kennedy has long promoted skepticism toward vaccines, including the childhood immunization schedule, despite overwhelming scientific evidence supporting vaccine safety and efficacy. His appointment as health secretary raised concerns among public health experts about potential rollbacks of vaccination programs.
The court's intervention reflects ongoing tension between Kennedy's stated intentions and established federal vaccine policy. The advisory commission plays a role in evaluating vaccine safety concerns and managing the Vaccine Injury Compensation Program, which handles claims from people alleging vaccine harm.
Kennedy's appeal seeks to overturn the freeze and allow the commission to resume operations under his direction. The outcome could influence how federal agencies approach vaccine recommendations and safety monitoring.
Public health officials have warned that changes to vaccination policy or reduced confidence in vaccines could harm immunization rates, particularly among children. The current measles vaccination rate in the United States stands below optimal levels in some regions, leaving communities vulnerable to outbreaks.
The legal battle underscores the stakes of Kennedy's leadership role in shaping federal health policy. His efforts to restructure vaccine-related advisory bodies continue to face judicial scrutiny.